Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1254-1258

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berthold, H.
Right arrow Articles by Ehmke, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berthold, H.
Right arrow Articles by Ehmke, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(D)-PENICILLAMINE
*NITRIC OXIDE

(Hypertension. 1999;34:1254.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Interaction Between Nitric Oxide and Endogenous Vasoconstrictors in Control of Renal Blood Flow

Heike Berthold; Armin Just; Hartmut R. Kirchheim; Heimo Ehmke

From I. Physiologisches Institut der Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.

Correspondence to Dr Heimo Ehmke, I. Physiologisches Institut der Ruprecht-Karls Universität, Im Neuenheimer Feld 326, D-69120 Heidelberg, Germany. E-mail ehmke{at}novsrv1.pio1.uni-heidelberg.de

Abstract—The level of renal blood flow (RBF) is controlled by opposing vasoconstrictor and vasodilator influences. In a recent investigation in normotensive dogs, we found that combined blockade of endothelin type A (ETA) receptors and angiotensin II formation induces marked increases in RBF that were much larger than the effects of blocking either system alone. The aim of the present study was to determine the contribution of nitric oxide (NO) to this vasodilator response. Experiments were made in 6 conscious, chronically instrumented dogs subjected to 5 different experimental treatments on separate days. Blockade of ETA receptors alone by the selective antagonist LU 135252 had only minor effects on RBF compared with time-control experiments. Additional blockade of angiotensin II formation by angiotensin-converting enzyme inhibition with trandolaprilat caused a substantial increase of RBF by {approx}50%. This vasodilation was entirely suppressed when NO formation was prevented by inhibition of NO synthase with NG-nitro-L-arginine methyl ester HCl. However, when during NO synthase inhibition renal vascular NO concentrations were clamped at control levels by infusing the NO donor S-nitroso-N-acetyl-D,L-penicillamine, the vasodilator response to combined blockade of ETA receptors and angiotensin II formation was completely restored ({Delta}RBF {approx}60%). These results indicate that the vasodilation after combined ETA receptor blockade and angiotensin-converting enzyme inhibition is not mediated by an increase in NO release but results from the unmasking of the tonic influence that is normally exerted by constitutively released NO. Accordingly, the tonic activity of endothelial NO synthase appears to be of major importance in the physiological regulation of renal vascular resistance by determining the vasomotor responses to endothelin and angiotensin II.


Key Words: endothelin • receptors, endothelin • nitric oxide • renal circulation • renin-angiotensin system




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
P. C. Colombo, D. Onat, and H. N. Sabbah
Acute heart failure as "acute endothelitis" -- Interaction of fluid overload and endothelial dysfunction
Eur J Heart Fail, February 1, 2008; 10(2): 170 - 175.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Montanari, N. Carra, P. Perinotto, V. Iori, E. Fasoli, A. Biggi, and A. Novarini
Renal Hemodynamic Control by Endothelin and Nitric Oxide Under Angiotensin II Blockade in Man
Hypertension, February 1, 2002; 39(2): 715 - 720.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. L.S. Pires, C. Barres, J. Sassard, and C. Julien
Renal Blood Flow Dynamics and Arterial Pressure Lability in the Conscious Rat
Hypertension, July 1, 2001; 38(1): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Just, H. Ehmke, L. Toktomambetova, and H. R. Kirchheim
Dynamic characteristics and underlying mechanisms of renal blood flow autoregulation in the conscious dog
Am J Physiol Renal Physiol, June 1, 2001; 280(6): F1062 - F1071.
[Abstract] [Full Text] [PDF]